Focal segmental glomerulosclerosis in children with idiopathic nephrotic syndrome. A report of the Southwest Pediatric Nephrology Study Group
- PMID: 3886999
- DOI: 10.1038/ki.1985.29
Focal segmental glomerulosclerosis in children with idiopathic nephrotic syndrome. A report of the Southwest Pediatric Nephrology Study Group
Abstract
Clinicopathologic correlations were examined in 75 children with focal segmental glomerulosclerosis (FSGS) associated with idiopathic nephrotic syndrome. The biopsy specimens of all patients were examined by electron microscopy (69 patients) or immunofluorescence microscopy (67 patients) in addition to light microscopy. Fifty-three patients (group A) had FSGS diagnosed on their first biopsy; 22 patients (group B) had one to three previous biopsies showing minimal glomerular changes or mesangial hypercellularity prior to the demonstration of FSGS on a subsequent biopsy. Considerable homogeneity between the diagnostic biopsy features in the two groups was evident. Diffuse mesangial hypercellularity and IgM deposition were found in a similar percentage of each group, but these features did not correlate with each other. To date, the mean duration of follow-up for the entire group has been 57 months (range, 7 to 217 months): 21% have developed ESRD, 23% have a decreased GFR but not ESRD, 37% have persistent proteinuria only, 11% are in remission, and 8% have been lost to follow-up. No morphologic or clinical features have been predictive of outcome during this relatively short period of followup. The frequency of chronic renal failure and ESRD has been similar in groups A and B. These data suggest that the clinical outcome in children with FSGS is poor in many patients, whether the diagnosis is established on an initial or subsequent renal biopsy specimen.
Similar articles
-
Evaluation and correlation of clinical and histological features of focal segmental glomerulosclerosis.Nephron. 1986;44(2):115-20. doi: 10.1159/000183978. Nephron. 1986. PMID: 3534606
-
Glomerular podocyte vacuolation in focal segmental glomerulosclerosis.Arch Pathol Lab Med. 1986 May;110(5):394-8. Arch Pathol Lab Med. 1986. PMID: 3754422
-
Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.Kidney Int. 2004 May;65(5):1690-702. doi: 10.1111/j.1523-1755.2004.00563.x. Kidney Int. 2004. PMID: 15086908
-
Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults.J Am Soc Nephrol. 1997 May;8(5):824-32. doi: 10.1681/ASN.V85824. J Am Soc Nephrol. 1997. PMID: 9176855 Review.
-
IgM nephropathy: is it closer to minimal change disease or to focal segmental glomerulosclerosis?J Nephrol. 2016 Aug;29(4):479-86. doi: 10.1007/s40620-016-0269-6. Epub 2016 Feb 3. J Nephrol. 2016. PMID: 26842624 Review.
Cited by
-
Cyclosporin A treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis.Klin Wochenschr. 1988 Nov 15;66(22):1126-37. doi: 10.1007/BF01727848. Klin Wochenschr. 1988. PMID: 3236762
-
Primary focal segmental glomerulosclerosis in Egyptian children: a 10-year single-centre experience.Pediatr Nephrol. 2010 Jul;25(7):1369-73. doi: 10.1007/s00467-010-1448-7. Epub 2010 Mar 2. Pediatr Nephrol. 2010. PMID: 20195645
-
IgM as a novel predictor of disease progression in secondary focal segmental glomerulosclerosis.Croat Med J. 2017 Aug 31;58(4):281-291. doi: 10.3325/cmj.2017.58.281. Croat Med J. 2017. PMID: 28857521 Free PMC article.
-
Predictors of long-term outcome of children with idiopathic focal segmental glomerulosclerosis.Pediatr Nephrol. 2007 Feb;22(2):215-21. doi: 10.1007/s00467-006-0264-6. Epub 2006 Dec 5. Pediatr Nephrol. 2007. PMID: 17146670
-
Efficacy of tacrolimus in the treatment of children with focal segmental glomerulosclerosis.World J Pediatr. 2014 May;10(2):151-4. doi: 10.1007/s12519-014-0484-y. Epub 2014 May 7. World J Pediatr. 2014. PMID: 24801235
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources